ACM
GSK icon

Altrius Capital Management’s GSK GSK Stock Holding History

Altrius Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
204,447
+11,267
+6% +$596K 2.04% 9
2026
Q1 		$10.7M Sell
193,180
-3,827
-2% -$207K 2.12% 9
2025
Q4 		$9.66M Sell
197,007
-33,110
-14% -$1.54M 2.05% 11
2025
Q3 		$9.93M Buy
230,117
+5,258
+2% +$205K 2.27% 3
2025
Q2 		$8.63M Sell
224,859
-960
-0.4% -$36.7K 2.02% 14
2025
Q1 		$8.75M Buy
225,819
+9,819
+5% +$359K 2.13% 8
2024
Q4 		$7.31M Buy
216,000
+17,578
+9% +$633K 1.96% 13
2024
Q3 		$8.11M Buy
198,422
+229
+0.1% +$9.37K 2.03% 13
2024
Q2 		$7.63M Buy
198,193
+3,231
+2% +$136K 2.01% 14
2024
Q1 		$8.36M Buy
194,962
+13,439
+7% +$554K 2.11% 7
2023
Q4 		$6.73M Buy
181,523
+26
+0% +$933 1.87% 14
2023
Q3 		$6.58M Buy
181,497
+1,419
+0.8% +$50.4K 1.95% 14
2023
Q2 		$6.42M Buy
180,078
+556
+0.3% +$19.9K 1.9% 16
2023
Q1 		$6.39M Buy
179,522
+5,827
+3% +$204K 1.95% 19
2022
Q4 		$6.1M Buy
173,695
+3,849
+2% +$128K 1.92% 13
2022
Q3 		$5M Buy
169,846
+85,373
+101% +$3.24M 1.91% 5
2022
Q2 		$4.6M Buy
+84,473
New +$4.66M 1.49% 18

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Altrius Capital Management's GSK Position: Q2 2026 in Review

Altrius Capital Management increased its GSK (GSK) stake by 5.8% in Q2 2026, buying an estimated $596K and bringing the position to 204,447 shares worth $10.7M. The position accounts for 2.04% of the portfolio, ranked #9.

Altrius Capital Management first reported a position in GSK in Q2 2022 and has held it in 17 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Altrius Capital Management held 204,447 shares of GSK worth $10.7M as of Q2 2026.
  • Altrius Capital Management bought 11,267 GSK shares in Q2 2026, an estimated $596K.
  • GSK made up 2.04% of Altrius Capital Management's portfolio in Q2 2026, its #9 holding.
  • Altrius Capital Management first reported a position in GSK in Q2 2022 and has held it in 17 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.